Notice: Meetings: Prostate cancer patients; CYP1B1*3 genotyping use to predict overall survival prior to treatment with docetaxel; licensing and collaborative research

March 4, 2017 | Author: Justia.com | Category: N/A

Embed

Donate

Report this link

Description

Download Notice: Meetings: Prostate cancer patients; CYP1B1*3 genotyping use to predict overall survival prior to treatment with docetaxel; licensing and collaborative research

Comments

SUPPORT DOCURI

We need your help!

Thank you for interesting in our services. We are a non-profit group that run this website to share documents. We need your help to maintenance this website.

Donate
Sharing

To keep our site running, we need your help to cover our server cost (about $400/m), a small donation will help us a lot.

No, thanks! Close the box.